InflaMed
En vente sur le marché américain (selon le DSLD)
Allergy Research Group, food supplement from the US market
InflaMed (Allergy Research Group), a food supplement au code-barres 713947747302, is described by its US market label, recorded on 22 August 2024. If sold in France, it would be subject to 4 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label, entered on 22 August 2024. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 20 mg a day according to the label (at most 2 servings a day), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Sélénium: up to 80 µg a day according to the label (at most 2 servings a day), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Dose déclarée au-delà d'une limite
Molybdène: up to 600 µg a day according to the label (at most 2 servings a day), above the maximum dose of 150 µg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Allergy Research Group
- Barcode
- 713947747302
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hydroxypropyl Methylcellulose, Microcrystalline Cellulose, L-Leucine
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Zinc | Mineral | 10 mg |
| Selenium | Mineral | 40 µg |
| Copper | Mineral | 1 mg |
| Molybdenum | Mineral | 300 µg |
| Methylsulfonylmethane | Other substance | 500 mg |
| Turmeric Root Extract (Curcuma longa) | Plant | 400 mg |
| Bromelain | Enzyme | 400 mg |
| Boswellin | Other substance | 200 mg |
| Ginger Root Extract | Plant | 40 mg |
| White Willow Bark Extract (Salix alba) | Plant | 50 mg |
Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: InflaMed
Entered into DSLD on 22 March 2024. Retirée du marché américain le 5 October 2023 (selon le DSLD).Same active composition.
Official label: InflaMed
Entered into DSLD on 18 December 2021. En vente sur le marché américain (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: Ginger extract in this version; Ginger Root Extract on the displayed label (40 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
- Same quantity, different name: Turmeric extract in this version; Turmeric Root Extract on the displayed label (400 mg)
- Same quantity, different name: White Willow extract in this version; White Willow Bark Extract on the displayed label (50 mg)
Official label: InflaMed
Entered into DSLD on 23 August 2020. Retirée du marché américain le 2 August 2021 (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
Official label: InflaMed
Entered into DSLD on 25 February 2019. Retirée du marché américain le 4 August 2020 (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
- Different quantity per serving : Selenium: 4 mcg in this version; 40 mcg on the displayed label
Official label: InflaMed
Entered into DSLD on 21 October 2017. Retirée du marché américain le 19 July 2018 (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
Official label: InflaMed
Entered into DSLD on 25 January 2016. Retirée du marché américain le 31 July 2017 (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
Official label: InflaMed
Entered into DSLD on 25 April 2013. Retirée du marché américain le 19 November 2015 (selon le DSLD).- Same quantity, different name: Indian Frankincense gum extract in this version; Boswellin on the displayed label (200 mg)
- Same quantity, different name: MSM in this version; Methylsulfonylmethane on the displayed label (500 mg)
Source
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging
Brand : Allergy Research Group